Small molecules & peptides
PSMA I&T acetate (GMP)
Precursor for radiometal-labelled PSMA I&T (PSMA: prostate-specific membrane antigen)
(R)-DOTAGA-(I-y)fk(Sub-KuE)
Sequence: (R)-DOTAGA-D-Tyr(3-I)-D-Phe-D-Lys[Sub-Glu-CO-Lys] acetate
Quality
GMP Product
Characteristics
Molar mass 1498.37 (PSMA I&T)
CAS RN [2192281-54-0] (PSMA I&T)
- White to off-white solid
- Tested for bioburden and bacterial endotoxins.
Literature
Baum R.P. et al. ¹⁷⁷Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy. J. Nucl. Med. 2016, 57, 1006–1013.
Eiber M. et al. Systemic Radioligand Therapy with ¹⁷⁷Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer. J. Nucl. Med., 2016, 57(supplement 2): p. 61–61.
Schottelius M. et al. [¹¹¹In] PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery. EJNMMI Res. 2015, 5, 68.
Add to inquiry
| Product | Product No. | Filling amount | Quantity | ||
|---|---|---|---|---|---|
| /products/small-molecules-and-peptides/chemical/68f88796-b1d1-4a33-abdb-6d8f390279c3 | Precursor | Product No.: 99383 |
Related products
Product was added